Autoimmune thrombocytopenia and hepatitis C virus infection. 1996

M Linares, and E Pastor, and F Hernández, and M Montagud, and A Blanquer

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D018937 Hepatitis C Antibodies Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins. Anti-HCV Antibodies,Anti-Hepatitis C Virus Antibodies,HCV Antibodies,Hepatitis C Virus Antibodies,Anti HCV Antibodies,Anti Hepatitis C Virus Antibodies

Related Publications

M Linares, and E Pastor, and F Hernández, and M Montagud, and A Blanquer
January 1998, Acta haematologica,
M Linares, and E Pastor, and F Hernández, and M Montagud, and A Blanquer
February 2009, Hematology (Amsterdam, Netherlands),
M Linares, and E Pastor, and F Hernández, and M Montagud, and A Blanquer
January 1994, Current studies in hematology and blood transfusion,
M Linares, and E Pastor, and F Hernández, and M Montagud, and A Blanquer
July 1994, FEMS microbiology reviews,
M Linares, and E Pastor, and F Hernández, and M Montagud, and A Blanquer
January 1998, Current studies in hematology and blood transfusion,
M Linares, and E Pastor, and F Hernández, and M Montagud, and A Blanquer
January 2012, International journal of general medicine,
M Linares, and E Pastor, and F Hernández, and M Montagud, and A Blanquer
February 1990, Lancet (London, England),
M Linares, and E Pastor, and F Hernández, and M Montagud, and A Blanquer
April 1990, Lancet (London, England),
M Linares, and E Pastor, and F Hernández, and M Montagud, and A Blanquer
December 1995, Journal of hepatology,
M Linares, and E Pastor, and F Hernández, and M Montagud, and A Blanquer
January 2017, Mediterranean journal of hematology and infectious diseases,
Copied contents to your clipboard!